http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f76931ef15a8e23017b457917d59aa15
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Bradbury |
| name | Charlotte Bradbury |
| given-name | Charlotte |
| organization-name | University Hospitals Bristol NHS Foundation Trust Bristol UK; Department of Cellular and Molecular Medicine University of Bristol Bristol UK Faculty of Health Sciences, University of Bristol, Bristol, UK University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, England The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group Department of Haematology Bristol Royal Infirmary Bristol UK Cellular and Molecular Medicine, Bristol Haematology and Oncology Centre University of Bristol Bristol UK University Hospitals Bristol NHS Foundation Trust Bristol UK Bristol Royal Informatory, Bristol, United Kingdom. University of Bristol, Bristol, United Kingdom. The LOVIT-COVID Investigators, on behalf of the Canadian Critical Care Trials Group, and the REMAP-CAP Investigators Cellular and Molecular Medicine, University of Bristol Bristol UK; Bristol Haematology and Oncology Centre Bristol UK Cellular and Molecular Medicine University of Bristol Bristol United Kingdom; Bristol Haematology and Oncology Centre University Hospitals Bristol NHS Foundation Trust Bristol United Kingdom |
Incoming Links
Total number of triples: 32.